SBIO
SBIO
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 KYMR | Kymera Therapeutics, Inc. | 4.22% | 66.46K | $5.97M |
 MIRM | Mirum Pharmaceuticals, Inc. | 3.36% | 49.13K | $4.76M |
 CGON | CG Oncology, Inc. Common stock | 3.26% | 68.61K | $4.62M |
 ALKS | Alkermes plc | 3.24% | 135.50K | $4.59M |
 CELC | Celcuity Inc. | 3.21% | 37.66K | $4.55M |
 APLS | Apellis Pharmaceuticals, Inc. | 3.00% | 104.06K | $4.25M |
 SYRE | Spyre Therapeutics, Inc. | 2.89% | 63.94K | $4.09M |
 APGE | Apogee Therapeutics, Inc. | 2.85% | 45.59K | $4.03M |
 XENE | Xenon Pharmaceuticals Inc. | 2.84% | 67.72K | $4.02M |
 FOLD | Amicus Therapeutics, Inc. | 2.61% | 255.62K | $3.70M |
 DNTH | Dianthus Therapeutics, Inc. | 2.43% | 36.21K | $3.44M |
 CRNX | Crinetics Pharmaceuticals, Inc. | 2.39% | 85.09K | $3.38M |
 VKTX | Viking Therapeutics, Inc. | 2.36% | 94.07K | $3.34M |
 NAMS | NewAmsterdam Pharma Company N.V. | 2.28% | 93.60K | $3.22M |
 TVTX | Travere Therapeutics, Inc. | 2.23% | 75.10K | $3.16M |
 ACAD | ACADIA Pharmaceuticals Inc. | 2.16% | 138.79K | $3.06M |
 GPCR | Structure Therapeutics Inc. | 2.16% | 57.48K | $3.06M |
 EWTX | Edgewise Therapeutics, Inc. | 2.04% | 87.33K | $2.90M |
 ORKA | Oruka Therapeutics, Inc. | 1.87% | 39.40K | $2.64M |
 DNLI | Denali Therapeutics Inc. | 1.83% | 128.84K | $2.60M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Netherlands
Ireland
Canada
Switzerland
China
Belgium
United Kingdom
GermanySECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Netherlands Ireland Canada Switzerland China Belgium United Kingdom GermanyHoldings (Top 20)
KYMR
Kymera Therapeutics, Inc.
MIRM
Mirum Pharmaceuticals, Inc.
CGON
CG Oncology, Inc. Common stock
ALKS
Alkermes plc
CELC
Celcuity Inc.
APLS
Apellis Pharmaceuticals, Inc.
SYRE
Spyre Therapeutics, Inc.
APGE
Apogee Therapeutics, Inc.
XENE
Xenon Pharmaceuticals Inc.
FOLD
Amicus Therapeutics, Inc.
DNTH
Dianthus Therapeutics, Inc.
CRNX
Crinetics Pharmaceuticals, Inc.
VKTX
Viking Therapeutics, Inc.
NAMS
NewAmsterdam Pharma Company N.V.
TVTX
Travere Therapeutics, Inc.
ACAD
ACADIA Pharmaceuticals Inc.
GPCR
Structure Therapeutics Inc.
EWTX
Edgewise Therapeutics, Inc.
ORKA
Oruka Therapeutics, Inc.
DNLI
Denali Therapeutics Inc.